Search

Home > The Bio Report > A Platform to Scale the Production of Personalized Cell Therapies
Podcast: The Bio Report
Episode:

A Platform to Scale the Production of Personalized Cell Therapies

Category: Business
Duration: 00:25:58
Publish Date: 2021-11-04 08:00:24
Description: While cell therapies have been advancing rapidly, therapies that rely on taking a patient’s own cells, altering them, and reinfusing them back into a patient are costly. Part of the reason why is that the process for doing this is labor intensive. Cellino Biotech has developed a platform for producing personalized autologous cell therapies in an automated and scalable fashion. We spoke to Marinna Madrid, co-founder and vice president of product, for Cellino, about the company’s platform technology for cell-based therapies, how it works, and why it may help enable a new era of personalized regenerative therapies.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes